ACC CardioOncology Course Aims to Help Clinicians Improve Survival, Quality of Life of Oncology Patients

Course to showcase latest research, evidence-based treatment strategies and best practices in growing field of cardiooncology

ACC – The American College of Cardiology will host the annual Advancing the Cardiovascular Care of the Oncology Patient virtual course with live sessions on Feb. 11-12, 2022, as well as on demand content. The course is intended for members of the entire interprofessional team, including cardiologists, oncologists, internists, pharmacists and nurses who provide health care to the growing population of cancer patients and survivors with cardiovascular concerns.

Experts from across the entire multidisciplinary care team will educate on improving awareness, identification, monitoring and management of cardiovascular diseases and conditions, as well as how to minimize cardiotoxicity from cancer therapies to help clinicians improve overall survival and quality of life for oncology patients.

Course co-directors Ana Barac, MD, PhD, FACC, and Bonnie Ky, MD, MSCE, FACC, have worked with respected experts in the field to create a course that will help the entire interprofessional team, at all levels of their careers, understand the different types of cancer therapies and how to mitigate the associated cardiovascular complications. The course will feature the latest research, best practices and case discussions on evidence-based treatment strategies with practical tips to comprehensively care for cancer patients and survivors.

Sessions Include:

  • Building Bridges in Cardio-Oncology – How to Improve Outcomes in Cancer Patients and Survivors
  • Immune Therapy and Cardiovascular Risk: What Do We Know and Where Does the Field Need to Go?
  • Cardioprotection: What Have the Clinical Trials Told Us?
  • The Growing Intersection Between CV Disease and Cancer: From Biology to Epidemiology
  • Health Care Disparities – How Can We Achieve Health Equity?

Posters

The following abstracts are a selection of posters being presented. All ACC Advancing the Cardiovascular Care of the Oncology Patients posters and abstracts are embargoed until Friday, Feb. 11 at 7 a.m. ET.

  • Assessment of Cardiovascular Disease Risk Factor Control in Triple Negative Breast Cancer Patients
  • Cardiovascular Disease in Patients with Thymic Cancer
  • Coronary Artery Calcium Burden as a Risk Factor for Adverse Cardiovascular Events in Patients with Lung Cancer Receiving Radiation Therapy (press release to follow)
  • Effectiveness of Virtual Cardio-Oncology Zoom Clinics on Long-term Patient Safety and Positive Satisfaction in a Tertiary Care Centre During COVID Pandemics
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version